PTE assessment
Three types of angiography for PTE assessment
There are three types of angiography for assessing whether a patient with a confirmed diagnosis of CTEPH is suitable for pulmonary thromboendarterectomy (PTE) surgery, also known as pulmonary endarterectomy (PEA).
Pulmonary angiography
Pulmonary angiography (digital subtraction angiography) is considered the gold standard for confirmation of CTEPH and evaluation of operability1
-
Defines extent and distribution of disease and helps distinguish operable from inoperable disease1
-
Combined with right heart catheterization (RHC), a correlation can be made between degree of disease and degree of hemodynamic impairment2,3
-
The procedure should always be carried out by experienced staff at a unit with specialist pulmonary hypertension (PH) experience, preferably the unit at which PTE surgery would be performed2,3
CT angiography
- Provides additional information regarding diagnosis and operability (eg, giving information on arterial walls)2,3
- Helpful in determining whether there is evidence of surgically accessible CTEPH2,3
- High-quality multidetector computed tomography pulmonary angiography (CTPA) may be a suitable alternative to pulmonary angiography in centers with experience in CTEPH1
- Note: Normal CT angiography does not exclude a diagnosis of CTEPH2,3
MRI angiography
-
Provides further information regarding diagnosis and operability, such as an evaluation of right-heart hemodynamics2,3
-
Noninvasive technique does not involve exposure to radiation, so it is suitable for repeated studies2,3
-
Note: Limited availability; may prove expensive and time consuming2,3
“A CTEPH team, consisting of an experienced PTE surgeon and CTEPH physicians, should assess operability before alternative treatments are considered. Close working collaboration between community providers and CTEPH centers is required.”1
Important Operability Assessment
Considerations
Watch as Dr Bill Auger of the PTE Program at UCSD reviews important considerations in evaluating CTEPH patients’ eligibility for potentially curative PTE surgery.
References:
1. Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(suppl D):D92-D99. 2. Wilkens H, Lang I, Behr J, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations of the Cologne Consensus Conference 2011. Int J Cardiol. 2011;154(Suppl 1):S54-S60. 3. Jenkins D, Mayer E, Screaton N, Madani M. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev. 2012;21(123):32-39.
